来源:医药魔方媒体
* 推文用于传递知识,如有版权等疑问,请联系我们。
- 上下滑动查看参考资料 -
[1]Robbie G. Majzner, et al. Clinical lessons learned from the first leg of the CAR T cell journey. Nature Medicine. (2019)
[2]Roddie, C., et al. Manufacturing chimeric antigen receptor T cells: issues and challenges. Cytotherapy. (2019)
[3]Rebecca C. Larson, et al. Recent advances and discoveries in the mechanisms and functions of CAR T cells. (2021)
[4]Robert C. Sterner, et al. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer Journal. (2021)
[5]Andrew J. Hou, et al. Navigating CAR-T cells through the solid-tumour microenvironment. Nature Reviews Drug Discovery. (2021)
[6]S. Depil, et al. ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges. Nature Reviews Drug Discovery . (2020)
往期精彩:
应用案例 | 为什么支原体快检要选 Lonza MycoAlert
为什么重组C因子可以代替鲎试剂用于内毒素检测?
火爆生物界的微流控技术(一):前世今生
Cocoon®和4D-Nucleofector™LV联用T细胞非病毒转导扩增方案
销售咨询
张经理:15895555869
技术咨询
赵经理:13162237306
渠道合作
顾经理:13564627120